NCT02615145View on ClinicalTrials.gov

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)

CompletedOBSERVATIONAL

Enrollment

472

Participants

Timeline

Start Date

December 3, 2015

Primary Completion Date

March 26, 2018

Study Completion Date

March 26, 2018

Conditions

Chronic Hepatitis C

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AbbVie

INDUSTRY